H.R. 8370 — Dietary Supplement Listing Act of 2026

This section establishes a dietary supplement listing requirement under the Federal Food, Drug, and Cosmetic Act, requiring the manufacturer, packer, or distributor named on the label (responsible person, or U.S. agent if foreign) to submit to FDA detailed product information—including name, ingredients with per-serving amounts and percent daily values (proprietary blend totals confidential), label copy, servings per container, directions, warnings, allergens, form, and specified claims—for each dietary supplement marketed in the U.S. (As background, dietary supplements are foods under the Dietary Supplement Health and Education Act of 1994 without premarket approval; this listing enables FDA to track marketed products, with a single submission allowed for similar formulations differing only in color, excipients, flavors, or package sizes.) FDA must notify submitters promptly of receipt and completeness (deemed complete once all fields are filled) and issue a product listing number for label inclusion; electronic submission may be required. For supplements marketed by January 1, 2027, listings are due within 18 months of enactment of the Dietary Supplement Listing Act of 2026, with labels required to show the listing number beginning two years after enactment; new supplements require listing and label number at introduction into interstate commerce.